|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pulmonary and Critical Care and The Heart Lung Institute, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210.
Correspondence to: Mark D. Wewers, MD, Division of Pulmonary and Critical Care, Department of Internal Medicine, The Ohio State University, N-325 Means Hall, 1654 Upham Dr, Columbus, OH 43210; e-mail: wewers.2{at}osu.edu
Objectives: To determine if the increased susceptibility to bacterial infection in asymptomatic HIV-infected patients is associated with decreased total IgG or IgG2 levels in lung epithelial lining fluid.
Background: A decrease in lung IgG levels or subtypes has been proposed as contributing to the increased risk of bacterial lung infections in HIV-infected patients. Previous studies measuring lung lavage IgG concentrations have been inconsistent.
Methods: Twenty-three HIV patients and 25 control subjects underwent BAL. Both patient groups were of similar age, and had similar pulmonary function studies and body mass index. Smokers were equally represented in both groups, and the majority of subjects in both groups were male. Total IgG and IgG2 levels in lavage fluid were assayed in both cohorts and compared using a two-tailed Students t test.
Results: The lung lining fluid IgG level in HIV-infected patients was 0.19 ± 0.13 µg/µg of protein (mean ± SD) vs 0.11 ± 0.09 µg/µg of protein in control subjects (p < 0.05). The IgG2 level in HIV patients was 0.034 ± 0.038 µg/µg of protein and 0.014 ± 0.01 µg/µg of protein in control subjects (p = 0.054). Lavage IgG levels reflected serum IgG values (correlation coefficient, 0.56; p < 0.001) but did not correlate with lung immunoglobulin-producing cells.
Conclusions: The increased susceptibility to bacterial pneumonia in asymptomatic HIV-infected individuals is neither explained by depressed total IgG levels nor a deficiency in IgG2 levels in the lungs. The strong correlation between serum and lavage IgG levels suggests that lavage IgG derives from serum.
Key Words: BAL fluid HIV infection immunoglobulin
This article has been cited by other articles:
![]() |
F J Wiedermann Alveolar and serum antiphospholipid antibodies in acute respiratory distress syndrome associated with catastrophic antiphospholipid syndrome Ann Rheum Dis, March 1, 2006; 65(3): 413 - 413. [Full Text] [PDF] |
||||
![]() |
H. L. Twigg III Humoral Immune Defense (Antibodies): Recent Advances Proceedings of the ATS, December 1, 2005; 2(5): 417 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beck The Immunocompromised Host: HIV Infection Proceedings of the ATS, December 1, 2005; 2(5): 423 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elssner, J. E. Carter, T. M. Yunger, and M. D. Wewers HIV-1 Infection Does Not Impair Human Alveolar Macrophage Phagocytic Function Unless Combined With Cigarette Smoking Chest, March 1, 2004; 125(3): 1071 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
F J Wiedermann, W Lederer, A J Mayr, N Sepp, M Herold, and W Schobersberger Prospective observational study of antiphospholipid antibodies in acute lung injury and acute respiratory distress syndrome: comparison with catastrophic antiphospholipid syndrome Lupus, June 1, 2003; 12(6): 462 - 467. [Abstract] [PDF] |
||||
![]() |
C. Mayaud, A. Parrot, and J. Cadranel Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients Eur. Respir. J., July 1, 2002; 20(36_suppl): 28S - 39s. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |